American College of Cardiology Supports FDA Efforts to End Access to Menthol Cigarettes, Flavored Cigars

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

American College of Cardiology President Dipti Itchhaporia, MD, FACC, made the following statement on the U.S. Food and Drug Administration’s (FDA) commitment to ban menthol cigarettes and flavored cigarettes.

“Tobacco use is the leading cause of preventable death in the United States and a significant, modifiable risk factor for heart disease, which is the No. 1 cause of death in the United States. This should give us ample reason to take every action available to reduce tobacco’s impact on our society and public health. The American College of Cardiology is heartened to see the FDA’s recent commitment to advance bans on menthol flavored cigarettes and all flavored cigars. The ACC has joined with stakeholders in recent years to call for this change as an imperative to public health.

It is already known that flavored products are often targeted at and used by our youth population. It is why flavored e-cigarettes have already been banned and why we have raised the age to use tobacco products to 21.

We all understand the stakes of tobacco products and addiction on our communities’ health. Menthol cigarettes are well-known to increase youth initiation to smoking; they also increase addiction to nicotine and reduce success in smoking cessation.

We also know that menthol cigarettes have an incredibly high toll in the disease and death in the Black community, worsening existing and unacceptable health disparities. The ACC, the public health community, the FDA and Congress must work together on this vital issue with clear public health benefits of reducing tobacco-related death and disease.”

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.